Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 25, 2009Proceedings of the National Academy of SciencesOpen Access

Intracerebroventricular amyloid-β antibodies reduce cerebral amyloid angiopathy and associated micro-hemorrhages in aged Tg2576 mice

View Full Paper
Ask AI
Bookmark
Share

Authors

DTDeepak R. ThakkerNovartis (Switzerland)MWMarcy R. WeatherspoonMedtronic (United States)JHJonathan HarrisonUniversity of Utah

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Thakker et al. (2009) studied this question.

synapsesocial.com/papers/6a73ddb71690e6770ff15c0bhttps://doi.org/10.1073/pnas.0813404106
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Insights into the mechanisms of action of anti‐Aβ antibodies in Alzheimer's disease mouse models2006 · 115 citations
  2. 2Anti-Aβ1–11 Antibody Binds to Different β-Amyloid Species, Inhibits Fibril Formation, and Disaggregates Preformed Fibrils but Not the Most Toxic Oligomers2007 · 93 citations
  3. 3Amyloid-β Immunization Effectively Reduces Amyloid Deposition in FcRγ-/-Knock-Out Mice2003 · 166 citations
  4. 4Internalized Antibodies to the Aβ Domain of APP Reduce Neuronal Aβ and Protect against Synaptic Alterations2007 · 119 citations
  5. 5Intracranially administered anti-Abeta antibodies reduce beta-amyloid deposition by mechanisms both independent of and associated with microglial activation.2003 · 267 citations